Brain metastases in lung cancer with targetable mutations: Should we allow targeted treatment in prognostic indices?

David M. Guttmann; Abigail T. Berman

doi:10.1001/jamaoncol.2016.7022

Brain metastases in lung cancer with targetable mutations: Should we allow targeted treatment in prognostic indices?

David M. Guttmann, Abigail T. Berman

Radiation Oncology

University of Pennsylvania

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	421-422
Number of pages	2
Journal	JAMA Oncology
Volume	4
Issue number	3
DOIs	https://doi.org/10.1001/jamaoncol.2016.7022
State	Published - Mar 2018

Keywords

Brain Neoplasms
Humans
Lung Neoplasms
Mutation
Prognosis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2016.7022

Cite this

@article{cf2138a5af054573a9fa768984e43c19,

title = "Brain metastases in lung cancer with targetable mutations: Should we allow targeted treatment in prognostic indices?",

keywords = "Brain Neoplasms, Humans, Lung Neoplasms, Mutation, Prognosis",

author = "Guttmann, {David M.} and Berman, {Abigail T.}",

year = "2018",

month = mar,

doi = "10.1001/jamaoncol.2016.7022",

language = "English",

volume = "4",

pages = "421--422",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "3",

}

TY - JOUR

T1 - Brain metastases in lung cancer with targetable mutations

T2 - Should we allow targeted treatment in prognostic indices?

AU - Guttmann, David M.

AU - Berman, Abigail T.

PY - 2018/3

Y1 - 2018/3

KW - Brain Neoplasms

KW - Humans

KW - Lung Neoplasms

KW - Mutation

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=85047464646&partnerID=8YFLogxK

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000426995100033&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1001/jamaoncol.2016.7022

DO - 10.1001/jamaoncol.2016.7022

M3 - Letter

C2 - 29049692

SN - 2374-2437

VL - 4

SP - 421

EP - 422

JO - JAMA Oncology

JF - JAMA Oncology

IS - 3

ER -

Brain metastases in lung cancer with targetable mutations: Should we allow targeted treatment in prognostic indices?

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this